Cargando…
Screening for Tay‐Sachs disease carriers by full‐exon sequencing with novel variant interpretation outperforms enzyme testing in a pan‐ethnic cohort
BACKGROUND: Pathogenic variants in HEXA that impair β‐hexosaminidase A (Hex A) enzyme activity cause Tay‐Sachs Disease (TSD), a severe autosomal‐recessive neurodegenerative disorder. Hex A enzyme analysis demonstrates near‐zero activity in patients affected with TSD and can also identify carriers, w...
Autores principales: | Cecchi, Alana C., Vengoechea, Elizabeth S., Kaseniit, Kristjan E., Hardy, Melanie W., Kiger, Laura A., Mehta, Nikita, Haque, Imran S., Moyer, Krista, Page, Patricia Z., Muzzey, Dale, Grinzaid, Karen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687860/ https://www.ncbi.nlm.nih.gov/pubmed/31293106 http://dx.doi.org/10.1002/mgg3.836 |
Ejemplares similares
-
Enfermedad de Tay Sachs
por: Cibrián Cruz, José Alberto
Publicado: (1996) -
Therapeutic Strategies For Tay-Sachs Disease
por: Picache, Jaqueline A., et al.
Publicado: (2022) -
Tay-Sachs Carrier Screening by Enzyme and Molecular Analyses in the New York City Minority Population
por: Mehta, Nikita, et al.
Publicado: (2016) -
New Approaches to Tay-Sachs Disease Therapy
por: Solovyeva, Valeriya V., et al.
Publicado: (2018) -
Characterization of Inducible Models of Tay-Sachs and Related Disease
por: Sargeant, Timothy J., et al.
Publicado: (2012)